KMDA · Kamada Ltd · Documents
$7.94
-0.12 (-1.43%)
At close · Oct 28
Return incl. dividend (before tax)
Q1 2026 earnings call transcript
Market Cap
$464.57M
Shares
57.71M
Volume · Oct 28
58.72K
Avg daily vol (3M)
123.95K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | Kamada launched Ustekinumab-Kamada and Enoxaparin-Kamada in Israel, expanding its interchangeable biosimilar portfolio to four products; it expects at least two more during 2027 and between approximately $20 million to $25 million in annual revenue by 2030. | 2026-10-06 | — | |
| 6-K | Kamada Ltd. did not capitalize pre-approval commercial-sale inventory costs for fiscal years ended December 31, 2025, and 2024, and plans expanded future disclosures about probable economic benefits and capitalizable cost types, if material. | 2026-10-05 | — | |
| 6-K | — | 2026-09-17 | — | |
| 6-K | — | 2026-09-10 | — | |
| F-3 | — | 2026-09-09 | — | |
| 6-K | — | 2026-09-03 | — | |
| 6-K | — | 2026-08-17 | — | |
| 6-K | — | 2026-08-12 | 2026-06-30 | |
| 6-K | — | 2026-08-05 | — | |
| 6-K | — | 2026-08-05 | — | |
| 6-K | — | 2026-07-20 | — | |
| 6-K | — | 2026-07-13 | — | |
| 6-K | — | 2026-06-18 | — | |
| 6-K | — | 2026-06-01 | — | |
| 6-K | — | 2026-05-13 | 2026-03-31 | |
| 6-K | — | 2026-05-06 | — | |
| 6-K | — | 2026-03-31 | — | |
| 6-K | — | 2026-03-26 | — | |
| 6-K | — | 2026-03-17 | — | |
| 6-K | — | 2026-03-11 | — | |
| 20-F | — | 2026-03-11 | 2025-12-31 | |
| 6-K | — | 2026-03-04 | — | |
| 6-K | — | 2026-01-07 | — | |
| 6-K | — | 2025-12-18 | — | |
| 6-K | — | 2025-12-10 | — | |
| 6-K | — | 2025-12-08 | — | |
| 6-K/A | — | 2025-12-02 | — | |
| 6-K | — | 2025-11-10 | 2025-09-30 | |
| 6-K | — | 2025-11-04 | — | |
| 6-K | — | 2025-10-23 | — | |
| 6-K | — | 2025-09-02 | — | |
| 6-K | — | 2025-08-13 | 2025-06-30 | |
| 6-K | — | 2025-08-11 | — | |
| 6-K | — | 2025-08-06 | — | |
| 6-K | — | 2025-06-17 | — | |
| 6-K | — | 2025-05-14 | 2025-03-31 | |
| 6-K | — | 2025-05-07 | — | |
| 6-K | — | 2025-05-05 | — | |
| 6-K | — | 2025-03-24 | — | |
| 6-K | — | 2025-03-19 | — | |
| 20-F | — | 2025-03-05 | 2024-12-31 | |
| 6-K | — | 2025-03-05 | — | |
| 6-K | — | 2025-02-26 | — | |
| 6-K | — | 2025-01-22 | — | |
| 6-K | — | 2025-01-08 | — | |
| 6-K | — | 2024-12-11 | — | |
| 6-K | — | 2024-11-13 | 2024-09-30 | |
| 6-K | — | 2024-11-06 | — | |
| 6-K | — | 2024-11-04 | — | |
| 6-K | — | 2024-10-21 | — |
Showing 1–50 of 161 filings